Industry Analysis Reports | Health Care | Medical Devices

Thursday, 8 July 2021

Dental Industry Market Demand to Forecast till 2027

Dental Industry Market Analysis

The global dental market is likely to grow at a 7.6% CAGR between 2018- 2023, as per the new report by Market Research Future (MRFR). The dental market comprises instruments, devices, treatment, and diagnosis associated with oral health. There are numerous problems related to oral health like discoloration or brown color in teeth, teeth cavity, pigmentation in gums, and others that are treated under the dental market.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/7637

Various factors are adding to the global dental market growth. Such factors, according to the new MRFR report, include rising geriatric population, the inclusion of 3D technology, increasing per capita income, better technological support, and rising cases of oral disease. Besides, demand for various dental procedures, rising prevalence of gum disease and oral cavity cancer & gum diseases, rise in technology, increasing awareness about oral health, consumers rising disposable income, changing lifestyles, and participation of health insurer reimbursements are also adding market growth.

On the contrary, low dental insurance coverage may limit the dental market growth over the forecast period.

Dental Industry Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global dental market report based on end users, discipline, and consumables.

By discipline, the global dental market is segmented into oral surgery, prosthodontics, orthodontics, restorative dentistry, endodontics, and periodontics.

By consumables, the dental market is segmented into endodontic supplies, dental anesthetic, dental syringe, dental biomaterial, gingival retraction material, dental burs, and whitening material. Dental biomaterial is again segmented into regenerative tissue material, dental cement, and dental bone graft. Gingival retraction material is again segmented into gingival retraction cap/gels/paste, gingival hemostatic agents, and gingival retraction cord. Dental anesthetic is again segmented into non-injectable anesthetic, topical anesthetics, and injectable anesthetic. Dental syringe is again segmented into non-disposable syringes and safety syringes/disposable syringes. Endodontic supplies are again segmented into cement and files.

By end user, the dental market is segmented into research institutes, dental hospitals and clinics, and dental institutes and dental academics.

Dental Industry Market Regional Analysis

Based on the region, the dental products market size report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period for a huge patient pool having different oral issues, presence of several market players, and demand for cosmetic surgery. Additional factors adding market growth include easy inclusion of technologies, infrastructural backing, and better scope for investment. Canada & the US are the chief contributors in the region for the rising number of patients needing help from dentists.

The dental market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the dental market growth in the region include gum problems, increasing tobacco consumption, and rising geriatric population. Besides, technological inclusion, better investment capacity, and Hungary being the dental tourism hub are also adding market growth.

The dental market in the APAC region is predicted to grow at the fastest pace over the forecast period for the changes in infrastructure and rising investments in the healthcare sector. Australia, Japan, India, and China are the chief contributors in the region.

The dental market in the MEA is predicted to have slow growth over the forecast period for the presence of countries that are economically poor.

Dental Industry Competitive Landscape

Leading players profiled in the global dental market report include Biomet, Zimmer Kangda Medical, 3M Company, Ultradent Products Inc., Young Innovations Inc., Patterson Companies Inc., Dentsply Sirona, Ivoclar Vivadent AG, Nakanishi Inc., Henry Schein Inc., and Hu-Friedy Mfg Co. Industry players have incorporated several strategies to stay ahead in the competition, such as geographic locations, mergers and acquisitions, expansions, joint ventures and collaborations, new product launch and development, contracts, and extensive R&D.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/dental-industry-market-7637

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Morphine (oral route) market size by top companies, demand and forecast

Medical Morphine Market synopsis:

Morphine is a pain medication which directly acts on the central nervous system to decrease acute and chronic pain. As per the report published by Market Research Future (MRFR), the global medical morphine market is anticipated to expand at a noteworthy CAGR of 7.5% during the forecast period of 2018-2023.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6084

Medical Morphine Market Drivers:

Morphine is a quintessential pain medication which is prescribed by licensed medical practitioners to the patients with acute or chronic pain. The increased use of morphine by the patients suffering from cancer, arthritis, myocardial infarction and other diseases is driving the expansion of the global medical morphine market. Increasing geriatric population and prevalence of diseases like arthritis, cancer and others are inducing demand for morphine in the market, leading to the growth of the global medical morphine market.

The application of medical morphine as a slow-release formulation for opiate substitution therapy (OST) in various countries such as Austria, Slovenia and others is fueling the growth of the global medical morphine market. The benefits of morphine in reducing the shortness of breath due to cancerous and non-cancerous causes is also impacting positively on the expansion of the global medical morphine market.

Market Restraints:

However, the increased awareness regarding the adverse effects of morphine on the human body such as constipation, hormonal imbalance, drowsiness, functional impairment and others are negatively impacting the growth of the global medical morphine market. The stringent regulatory framework imposed by the government to limit the amount of morphine to be prescribed owing to the high abuse rate of morphine is acting as a restraint on the expansion of the global medical morphine market.

Market Segmentation:

The global morphine (oral Route) market has been segmented on the basis of route of administration, application, distribution channel and end-users. Based on route of administration, the medical morphine market is segmented into oral and injectable. Based on application, the medical morphine Market is segmented into arthritis, cancer, kidney stone, myocardial infarction, diarrhea and others. Based on distribution channel, the medical morphine market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. Based on end-users, the medical morphine market is segmented into hospitals and clinics, ambulatory surgical centers, homecare, and others.

Regional Analysis:

The global medical morphine market is geographically segmented into four major regions such as Americas, Asia Pacific, Europe, and the Middle East and Africa. The Americas account for the largest market share in the global medical morphine market owing to the increasing demand for opioid drugs as pain relievers.

The Europe region accounts for the second largest market share in the global medical morphine market owing to the increasing prevalence of diseases like cancer, myocardial infarction and others. The medical morphine market in the Asia Pacific region is projecting noteworthy growth due to the increasing geriatric population and rise in use of medical morphine as pain medication in this region.

The Middle East and Africa region is anticipated to project steady growth in the global medical morphine market due to the limited availability of medical facilities, poor healthcare infrastructure, and lack of awareness among the population in underdeveloped areas of this region.

Competitive Analysis:

The increasing number of investors in the global medical morphine market is strengthening the competition among the players of the global medical morphine market. The high research and development expenditure by the pharmaceutical industries in order to launch new products in the global market and strategic mergers and acquisition by the players in the market is leading to the expansion of their businesses in the global medical morphine market.

In July 2018, Aurobindo Pharma, an Indian pharmaceutical company has announced that it is in its final stage of negotiation to acquire Mallinckrodt’s specialty generics business in the US including its portfolio of opioid-based painkillers such as morphine. This is considered to be the largest cross-border acquisition by an Indian pharmaceutical company in the recent times.

The key players of the global medical morphine market that are highlighted in the report published by MRFR are Mallinckrodt Pharmaceuticals, Alcaliber S.A, Purdue Pharma L.P., Pfizer Inc., Johnson Matthey Fine Chemicals, Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Taj Pharmaceuticals Limited, NORTHEAST PHARM, and MANUS AKTTEVA BIOPHARMA LLP.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/medical-morphine-market-6084

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bone pain treatment market global Demand and Regional Forecast

Market Highlights

The global Osteomyelitis Market is expected to register an approximate CAGR of 6.1% during the forecast period.

The increasing prevalence of osteomyelitis, growing child population, and growing cases of diabetes are estimated to drive the market during the forecast period. However, factors such as the limited availability of treatments, risks associated with surgery, and low healthcare expenditure in the middle and low-income countries are estimated to restraint the market growth, during the forecast period.

Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6042

Segmentation

The global Bone pain treatment market is segmented on the basis of pathogenesis, diagnosis and treatment, and end-user.

The market for osteomyelitis is segmented by pathogenesis which is sub-segmented into trauma, contiguous spread, and others. By diagnosis, the market is categorized into physical examination, blood tests, imaging tests, bone biopsy, and others. The blood tests segment is sub-segmented into Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), and C-Reactive Protein (CRP). The imaging segment is sub-segmented into X-rays, Computerized Tomography (CT) scan, and Magnetic Resonance Imaging (MRI). By treatment, the market is segmented into antibiotics and surgery. The antibiotics segment is sub-segmented into ceftriaxone, nafcillin, ceftazidime, and others. By end-user, the market is segmented into hospitals and clinics, research organizations, diagnostic diseases, and others.

Regional Analysis

The Americas dominates the global market for osteomyelitis. Huge patient population, high per capita income, the presence of market players, and developed economies such as the U.S. and Canada within the region provide favorable backgrounds for market growth. Europe is second in the market owing to the increasing acceptance of therapeutic surgeries, the presence of a developed healthcare sector, and rising reported cases of diabetes within the region. Asia Pacific is estimated to be the fastest growing region for the global osteomyelitis market owing to the increasing prevalence of diabetes, rising medical tourism, and an expanding healthcare sector within the region. The Middle East and Africa holds the least share in the global osteomyelitis market owing to the presence of poor economies, stringent government policies, and low per capita income, especially within the African region.

Key Players

Some of the key players for the global osteomyelitis market are Allergan Plc (Republic of Ireland) CrystalGenomics Inc (South Korea), Debiopharm International SA (Lausanne), Motif Bio Plc (London), Nabriva Therapeutics AG (Dublin), Vyome Biosciences Pvt Ltd (India), F. Hoffmann-La Roche AG (Switzerland), Koninklijke Philips N.V. (Netherlands), General Healthcare (U.S.), Siemens AG (Germany), Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), and others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Osteomyelitis Market, By Diagnosis And Treatment

6.1 Introduction

6.2 Diagnosis And Treatment

Market Estimates & Forecast, 2018–2023

6.2.1 Physical Examination

Market Estimates & Forecast, 2018–2023

6.2.2 Blood Tests

Market Estimates & Forecast, 2018–2023

6.2.2.1 Complete Blood Count (CBC)

6.2.2.2 Erythrocyte Sedimentation Rate (ESR)

6.2.2.3 C-Reactive Protein (CRP)

6.2.3 Imaging Tests

Market Estimates & Forecast, 2018–2023

6.2.3.1 X-Rays

6.2.3.2 Computerized Tomography (CT) Scan

6.2.3.3 Magnetic Resonance Imaging (MRI)

6.2.3.4 Others

6.2.4 Bone Biopsy

6.2.5 Others

6.3 Treatment

Market Estimates & Forecast, 2018–2023

6.3.1 Antibiotics

Market Estimates & Forecast, 2018–2023

6.3.1.1 Ceftriaxone

6.3.1.2 Nafcillin

6.3.1.3 Ceftazidime

6.3.1.4 Others

6.3.2 Surgery

Market Estimates & Forecast, 2018–2023

Chapter 7. Global Osteomyelitis Market, By Pathogenesis

Market Estimates & Forecast, 2018–2023

7.3.1 Trauma

7.3.2 Contiguous Spread

7.3.3 Others

Chapter 8. Global Osteomyelitis Market, By End-User

8.1 Introduction

8.2 Hospital And Clinics

Market Estimates & Forecast, 2018–2023

8.3 Research Organization

Market Estimates & Forecast, 2018–2023

8.4 Diagnostic Centers

Market Estimates & Forecast, 2018–2023

8.5 Others

Chapter 9. Global Osteomyelitis Market, By Region

Continued…
Obtain Complete Research Report with Toc, Graph and Figure @

https://www.marketresearchfuture.com/reports/osteomyelitis-market-6042

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Wednesday, 7 July 2021

Analysis on Veterinary Computed Tomography Scanner Market Size, Share and Trends by 2027

The global veterinary CT scanner market is expected to rise at a strong 6.2% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The market was valued at a paltry USD 138.1 million in 2018, but is likely to grow at a rapid rate over the forecast period due to the increasing awareness about pet health and the use of CT scanners in ensuring and maintaining pet health. The report also contains a detailed analysis with regard to the COVID-19 pandemic, and states how the pandemic is likely to affect the market in the short and long term. The report also presents a detailed analysis of the market with respect to the major drivers and restraints affecting the global veterinary CT scanner market and the leading players operating in the global market.

Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/5984

Veterinary CT scanners are equipment used to diagnose anomalies and diseases in animals specifically. Veterinary CT scanners can be used to diagnose cancers, cardiovascular diseases, trauma, and musculoskeletal disorders, among others, in pets and other domestic animals. The growing prevalence of cancer in pet animals is a major driver for the global veterinary CT scanner market and is likely to drive the market at a steady rate over the forecast period. Growing awareness among pet owners about animal cancer is also a major driver for the global veterinary CT scanner market, as this has driven the number of diagnostic tests for cancer. The increasing usage of advanced medical equipment for diagnosing problems in pet animals is likely to be a major driver for the global veterinary CT scanner market over the forecast period.

The increasing number of pets being adopted all over the world is likely to be a major driver for the global veterinary CT scanner market over the forecast period. According to the American Society for the Prevention of Cruelty to Animals, around 3.2 million shelter animals are adopted each year. This high number has led to growing prospects for the veterinary CT scanner market, as the number of pets under care in the developed world has grown rapidly. Increasing awareness about pet health and increasing readiness among pet owners to carry out investigative procedures to diagnose diseases in their pet animals is also a major driver for the global veterinary CT scanner market over the forecast period.

Veterinary CT Scanner Market- Competitive Leaderboard:

Leading players in the global Veterinary Computed Tomography Scanner Market include GNI ApS, Animage LLC, Hitachi Ltd., Samsung Electronics Co. Ltd., Siemens AG, Epica International Inc., Canon Inc., SOUND, GE Healthcare, and Koninklijke Philips NV. Major players in the global veterinary CT scanner market are likely to engage in merger and acquisition activity to increase their share in the global market. Strategic collaborations are also likely to be popular among players in the global veterinary CT scanner market over the forecast period.

Veterinary CT Scanner Market- Segmentation:

The global veterinary CT scanner market is segmented on the basis of type, slice, animal type, application, end use, and region.

By type, the global veterinary CT scanner market is segmented into stationary multi-slice CT scanners and portable CT scanners. The stationary multi-slice CT scanners segment is expected to dominate the global veterinary CT scanner market over the forecast period due to the enhanced functionality of stationary CT scanners in comparison to portable ones, which sacrifice some functionality in order to gain more convenience. The increasing use of stationary CT scanners in large hospitals and clinics is the major driver for the stationary multi-slice CT scanner segment over the forecast period.

By slice, the global veterinary CT scanner market is segmented into 4 slice, 8 slice, 16 slice, 32 slice, and 64 slice.

By animal type, the global veterinary CT scanner market is segmented into small and large animals.

By application, the global veterinary CT scanner market is segmented into cancer, cardiovascular diseases, infectious diseases, appendicitis, trauma, musculoskeletal disorders, and others.

By end use, the global veterinary CT scanner market is segmented into veterinary clinics, veterinary hospitals, and academic institutes.

Veterinary CT Scanner Market - Regional Analysis:

The Americas dominate the global veterinary CT scanner market, followed by Europe.

Global Veterinary CT Scanner Market, by Region

Americas

North America

US
Canada

Latin America

Europe

Western Europe

Germany
France
Italy
Spain
UK
Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan
China
India
Australia
South Korea
Rest of Asia-Pacific

Middle East & Africa

Middle East
Africa

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/veterinary-ct-scanner-market-5984

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Tuesday, 6 July 2021

Non-destructive medical technologies Market 2021- Global Demand, Key Players, Opportunity Assessment,

Market Highlights

Emergence of next-generation non-destructive technologies including X-ray computed tomography, and phased array ultrasonic are expected to replace the traditional technologies, which will offer prominent opportunities for the development of non-destructive technologies market growth during 2017-2023. Now a days, these technologies are used for the detection of thyroid, breast, lung, and ovary cancer. Cancer is one of the major problem across the globe and there is continuous development in the diagnostic and treatment method of cancer. With the help of advanced sensors & semiconductors, and technologies, a new instrument named as MasSpec Pen was designed, & built by researchers at the University of Texas at Austin. Introduction of MasSpec Pen has modernize the detection of cancer. During the clinical trials, MasSpec Pen has proven accurate in over 96 percent of test cases.

Increasing prevalence of cancer, rising need for better diagnostic treatment, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drives the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology fuels the market growth during the forecast period. However, long approval time, and high cost of the devices may slow the market growth during the forecasted period.

The global non-destructive testing market is expected to grow at a CAGR of ~ 10.8 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominates the global non-destructive medical technologies market owing to the presence of huge patient with cancer, high healthcare spending, and increasing government support for research & development. Europe holds the second largest share of the global non-destructive medical technologies market followed by Asia Pacific. Asia Pacific is the fastest growing non-destructive medical technologies market. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India during the forecasted period. The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global non-destructive medical technologies market has been segmented on the basis of methods, application, products, and end user.

On the basis of methods, the market is segmented into echocardiography, medical ultrasonography, liquid penetrant, phased array ultrasonic testing, and digital radiography.

On the basis of equipment, the market is segmented into ultrasonic equipment, X-ray equipment, infra-red devices, and mass spectrometer.

On the basis of application, the market is segmented into diagnosis, and treatment.

On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, forensic laboratories, research organizations, and others.

Key Players

Some of key the players in the market are Eberlin Lab (US), Carestream Health (US), General Electric Company (US), Olympus Corporation (Japan), Element Materials Technology (US), Fischer Technology Inc. (US),Magnaflux Corporation (US), Sonotron NDT (Israel), Zetec Inc. (US), Sonatest Ltd. (UK), and Eddyfi NDT Inc. (Canada).

Access Report Details @ https://www.marketresearchfuture.com/reports/non-destructive-medical-technologies-market-4396

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Anti-Ageing Drugs Market Size, Share, Trend, Data Statistics Analysis by 2027

Market Synopsis of Global Anti-ageing drugs Market

“Botox has helped her get ready faster!” said Kelly Ripa on the show “Watch What Happens Live with Andy Cohen”. Gone is the time when one would find anti-ageing products only in the cabin baggage of international flights and the makeup rooms of top notch artists! Anti-aging drugs are used to slow down or reverse the process of aging in order to extend the lifespan. Anti-ageing drugs are no longer taboo even in dusky small towns. Today’s women even from developing countries are as modern and demanding as their western counterparts. Thus we expect the differential between west and east regarding anti-ageing drugs to fall from its colossal heights of the 80’s! The global anti-ageing drugs market is expected to reach USD 124,896.6 million by 2023, and the market is projected to grow at a CAGR of ~ 13.3 % during the forecast period 2017-2023.

Market dynamics of Global Anti-ageing drugs Market

The global anti aging industry statistics is driven by factors such as the rising number of ageing population, growing demand for anti-aging drugs, influence of media and fashion industry, and primal demand to be young. The social and attitudinal aspects of a region or nation also have a large impact on the market and so is the influence of the media. Anti-aging drugs market is currently in its infant stage and there is a lot of scepticism about its future. According to the World Health Organization (WHO), the proportion of the world's population over 60 years between 2015 and 2050 will nearly double from 12% to 22%. Further, as per WHO estimates, by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries.

Critical market constraints are scepticism, concerns of safety, stringent regulations and definition ambiguity etc. Many spurious products with dubious claims are easily available on the web that has spurred a flood of self-proclaimed experts proposing growth hormones, skin-care products, beta glucan, and a variety of dietary and nutritional supplements with claims that are difficult to validate. The definition issues are also huge as the Food and Drug Administration has repeatedly warned many producers of anti-ageing medicines of such claims. The definition of cosmeceuticals is not agreed by many administrative bodies. There are issues of counterfeit products and misbranding, which reduces the market for quality products from reputed manufacturers. Lack of experimental studies to validate the claims made by manufacturers has complicated the situation.

Market strategies of players

Brand awareness and brand loyalty plays a critical role in the global anti-ageing drugs market. Established market players must focus on the product development as well as market development strategies. Maintaining market equity is of utmost importance as the market is highly integrated and specialized. Lack of any effective drug is likely to make any novel drug an immediate market leader with minimal marketing cost and efforts.

Collaboration and distribution agreements are another strategies taken by players. For example, Lakme has joined hands with HLL so as to reduce competition from similar brands from other companies. Cashing in on a single brand so as to build market position, brand and future market equity is an attractive market entry strategy.

Segments of Global Anti-ageing drugs Market

The global anti-ageing drugs market has been segmented on the basis of drug class and applications. On the basis of drug class, the market is segmented into serums and supplements, antioxidants and enzymes, stem cells and drugs. On the basis of application, the market is segmented into skin and hair, skeletal and muscles, age related disorders and others.

Serums and supplements segment commanded the largest market share in 2016 and is expected to reach USD 51,590.5 million by the end of 2023. Furthermore, stem cells segment is expected to be the fastest growing market which is expected to grow at a CAGR of 16.6 % during the forecast period 2017-2023. Skin and hair segment commanded the largest market share in 2016. This market is expected to reach USD 72,222.3 million by 2023, at a CAGR of 15.9 % during the forecast period 2017-2023

Regional Analysis of Global Anti-ageing drugs Market

The Americas holds a significant market share followed by Europe. The high per capita income of the US, the presence of large innovative players in healthcare of the U.S. regions drive the anti-ageing drugs market. The ageing population of baby boomers is expected to propel the market in the US. North America held the largest market share in 2016. This market is expected to reach USD 42,470.5 million by 2023, at a CAGR of 13.4 % during the forecast period of 2017-2023

Europe is the second largest market in the globe due to a high healthcare expenditure and influence of media industry. Asia Pacific region is expected to grow rapidly; Japan, China and India are likely to lead the market due to unmet needs during the forecasted period. APAC is expected to grow at a higher CAGR of 15.3 % than the other regions because of increasing ageing population in this region.

Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Key Players in the Global Anti-Ageing Drugs Market

Some of key players profiled in the report are Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche-Posay, DermaFix, L'ORÉAL, and others.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

GallBladder Treatment Market, Segments, Growth And Value Chain Analysis 2027

Market Insights

Gall bladder diseases afflict a significant number of people on a regular basis. In 2013 more than 100 million people were diagnosed with gallbladder and related diseases which resulted in more than 100,000 deaths. The gall bladder is a vital organ which stores bile produced by the liver and pass it along a duct which then empties into the small intestine. Market Research Future has dedicated valuable resources to the research of the global gall bladder treatment market. Calculation regarding market growth reveals a CAGR of 6.5% during the forecast period between 2017 and 2023. The market is expected to reach an evaluation of USD 27,121.5 Mn by the end of 2023.

The biggest driver of the gall bladder treatment market is the increasing prevalence of gall bladder diseases caused primarily by a sedentary lifestyle and/or poor lifestyle habits. Aggressive alcohol abuse or poor eating habits are likely to trigger gall bladder diseases. The increasing prevalence of gall bladder disease has resulted in increased awareness with regards to gall bladder diseases and treatment and has driven high demand for effective gall bladder treatment. The adoption of advanced diagnostic has also encouraged the demand for advanced treatment options which are minimally invasive. Moreover, the presence of a large and rapidly growing geriatric population is expected to have a significant impact on the market in a positive manner. Emerging economies are prime regions for the expansion of the market, and they display high opportunity for growth during the forecast period.

Despite healthy growth during the forecast period, the complications and pain associated with gall bladder surgery and recovery, combined with the asymptomatic nature of gallstones will likely slow market growth during the assessment period.

GallBladder Treatment Market Segmentation

The global gall bladder cancer treatment market is segmented on the basis of disease indication, diagnosis, treatment, end-users, and region. On the basis of disease indication the global gall bladder treatment market has been segmented into gallbladder polyps, gallbladder cancer, cholecystitis & biliary colic, gall stone, and cholelithiasis & choledocholithiasis. Gallstones make up 24.5% of the total share of the market making the gallstones segment the largest segment.

Diagnosis has been segmented into computerized tomography (CT), ultrasound, blood tests, and cholangiography & hepatobiliary scintigraphy. The ultrasound segment is captured maximum market share. However, the CT segment is projected to witness growth at a CAGR of 7.10% during the review period.

Treatment has been divided between surgery and drugs. Surgery accounts for the most significant share of the market by treatment and is expected to reach a substantial market value by the end of 2023.

End-users include hospitals & gynecology clinics, and academic & research centers.

GallBladder Treatment Market Regional Analysis

North America has reached the forefront of the global market due to the presence of a significant patient population which is afflicted by gall bladder disease. In North America, the U.S holds the largest market share. Developed economies tend to have a higher prevalence of gallbladder diseases. Europe is the second largest regional market for gall bladder treatment. The presence of a developed healthcare sector and high healthcare expenditure has secured Europe its leading market position. Meanwhile, the Asia Pacific is growing in prominence as a regional market in the global market for gall bladder treatment. Awareness regarding gall bladder disease and the increased demand for treatments as well as the presence of a massive patient population is expected to drive the APAC market. APAC is expected to grow at a CAGR of 7.0% during the review period.

GallBladder Treatment Market Key Players

Dornier MedTech, Boston Scientific Corporation, B. Braun Melsungen AG, Sanofi, Intuitive Surgical, Koninklijke Philips N.V., C. R. Bard, Inc. and others have been identified and included in MRFR's analysis of the competition in the global gall bladder treatment market.

Browse Complete Report With Toc @ https://www.marketresearchfuture.com/reports/gallbladder-treatment-market-3945

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Thursday, 8 July 2021

Dental Industry Market Demand to Forecast till 2027

Morphine (oral route) market size by top companies, demand and forecast

Bone pain treatment market global Demand and Regional Forecast

Wednesday, 7 July 2021

Analysis on Veterinary Computed Tomography Scanner Market Size, Share and Trends by 2027

Tuesday, 6 July 2021

Non-destructive medical technologies Market 2021- Global Demand, Key Players, Opportunity Assessment,

Anti-Ageing Drugs Market Size, Share, Trend, Data Statistics Analysis by 2027

GallBladder Treatment Market, Segments, Growth And Value Chain Analysis 2027

Blog Archive

Total Pageviews